Cancer kills less in US, but prevention lacking

January 7, 2013 by Jean-Louis Santini in Cancer

Fewer people are dying from cancer in the United States, but a government report published Monday warned that a lack of preventative measures could stem a steady decline in mortality rates.

have been falling since the early 1990s. The study found that from 2000 to 2009, cancer death rates decreased by 1.8 percent per year among men and by 1.4 percent per year among women.

Death rates among children up to 14 years of age also continued to decrease by 1.8 percent per year, according to the Annual Report to the Nation on the Status of Cancer.

Overall cancer incidence rates fell 0.6 percent per year among men from 2000 to 2009, while rates were stable among women and rose by 0.6 percent per year among children under the age of 15.

"While this report shows that we are making progress in the fight against cancer on some fronts, we still have much work to do, particularly when it comes to preventing cancer," said Thomas Frieden, director of the .

"For example, vaccinating against (the sexually transmitted disease) HPV can prevent , but, tragically, far too many girls are growing into adulthood vulnerable to cervical cancer because they are not vaccinated."

The study found that fewer than half of US girls aged 13 to 17 had received at least one dose of the vaccine and only 32 percent had received all three recommended doses in 2010.

This falls well short of the government's targets and of of 50 to 85 percent in neighboring Canada and of more than 70 percent in the United Kingdom and Australia.

It comes as HPV-associated are on the rise.

"The continuing drop in over the past two decades is reason to cheer," said John Seffrin, of the American Cancer Society, which co-authored the study.

"The challenge we now face is how to continue those gains in the face of new obstacles, like obesity and .

"We must face these hurdles head on, without distraction, and without delay, by expanding access to proven strategies to prevent and control cancer."

The report also found that death rates among men decreased for 10 of the 17 most common cancers (lung, prostate, colon and rectum, leukemia, non-Hodgkin lymphoma, kidney, stomach, myeloma, oral cavity and pharynx and larynx) and increased for melanoma of the skin and cancers of the pancreas and liver.

Death rates for women decreased for 15 of the 18 most common cancers (lung, breast, colon and rectum, ovary, leukemia, non-Hodgkin lymphoma, brain and other nervous system, myeloma, kidney, stomach, cervix, bladder, esophagus, oral cavity and pharynx, and gallbladder) and increased for cancers of the pancreas, liver and uterus.

Meanwhile, incidence rates for women decreased for seven of the 18 most common cancers (lung, colon and rectum, bladder, cervix, oral cavity and pharynx, ovary and stomach), and increased for seven others (thyroid, melanoma of the skin, kidney, pancreas, leukemia, liver and uterus).

Incidence rates were stable for the other top 17 cancers, including breast cancer in women and non-Hodgkin lymphoma in men and women.

Cancer kills more than 1,500 people a day in the United States. That's 301,820 men and 275,370 women in 2012, according to the latest estimates by the .

About 1.6 million Americans are diagnosed with cancer every year.

(c) 2013 AFP

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Racial disparities in the surgical management of non-small cell lung cancer

The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.

Cancer created 1 hour ago | popularity not rated yet | comments 0

Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency

Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...

Cancer created 1 hour ago | popularity not rated yet | comments 0

New tumour-killer shows great promise in suppressing cancers

Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.

Cancer created 2 hours ago | popularity 5 / 5 (1) | comments 0

New factor to control oncogene-induced senescence

An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Anti-CD47 antibody may offer new route to successful cancer vaccination

(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...

Cancer created 4 hours ago | popularity not rated yet | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Study shows where scene context happens in our brain

In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Genetic predictors of postpartum depression uncovered

Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.

Monoclonal antibody appears effective and safe in asthma Phase IIa trial

A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.